Modulating the Immune System
Home
About
Active Biotech in Brief
Board of Directors
Management
Business Concept
Corporate Governance
Corporate Governance Report 2017
Article of Association
Election Committee
General Meetings
Auditors
Partnerships
Career
Projects
Project Overview
ANYARA
Tasquinimod
SILC
Laquinimod
Paquinimod
Patents
Orphan Drug Designation
Investor
Investor
Financial Calendar
Financial Reports
Interim Reports
Annual Reports
Stock
Ownership
Official Documents
Rights Issue 2014
Rights Issue 2016
Rights Issue 2018
Media
Press Contact
Press Releases
Subscribe
News
Company Presentation
Image Bank
Contact
Copyright © 2019 Active Biotech AB.
All Rights Reserved.
Design by
Clavis Communications
.
Media
Press Contact
Press Releases
Subscribe
News
Company Presentation
Image Bank
Press Releases
Active Biotech's Novel MS Compound laquinimod Featured in the Scientific Publication The Lancet
June 20, 2008 06:26 (CEST)
<
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
>
This site uses cookies.
Okay, thanks
